Integrating expedited partner STI therapy during PrEP delivery for young women
在年轻女性的 PrEP 分娩过程中整合快速伴侣性传播感染治疗
基本信息
- 批准号:10158133
- 负责人:
- 金额:$ 60.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-22 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:Bedside TestingsChlamydia trachomatisClinical TrialsCollaborationsCost AnalysisCounselingDataData AnalysesDiagnostic testsDisclosureEctopic PregnancyEducational workshopEnrollmentExposure toFemale AdolescentsFrightGoalsGuidelinesHIVHIV-1Health PersonnelHigh Risk WomanIncidenceInfectionInfertilityInterviewKnowledgeLeadMethodsModalityNeisseria gonorrhoeaeOralOutcomeParticipantPelvic Inflammatory DiseasePersonsPlayPolicy MakerPopulationPopulations at RiskPreventionPrevention ResearchProcessProspective cohort studyPublic HealthRecommendationRecurrenceReportingReproductive HealthResearchResourcesRiskRoleSTI preventionSamplingSexual HealthSexual PartnersSexually Transmitted DiseasesSouth AfricaSouth AfricanSustainable DevelopmentSwabSymptomsSyndromeSyphilis SerodiagnosisTMC120-R147681Target PopulationsTestingTimeTrichomonas vaginalisVaginaVaginal RingVisitWomanagedchronic infectioncomparativecostcost estimateexperiencefollow-uphigh standardinfection rateinterestlow and middle-income countriesmalemicrocostingneonatal infectionpeerpoint of carepoint-of-care diagnosticspre-exposure prophylaxispreventscale upscreeningsexual HIV transmissionsocialstandard of careuptakeyoung woman
项目摘要
PROJECT SUMMARY
Adolescent girls and young women (AGYW) in South Africa have one of the highest HIV-1 incidences globally
and are a key target population for oral pre-exposure prophylaxis (PrEP) to prevent HIV-1 acquisition. In addition,
AGYW seeking PrEP frequently experience high rates of curable sexually transmitted infections (STIs). Current
South African PrEP guidelines recommend syndromic management for STIs, meaning that only women reporting
symptoms will receive treatment. It is well-established that syndromic management is particularly problematic
for women as the vast majority of curable STIs are asymptomatic. Persistent, untreated infections can lead to
serious reproductive health outcomes, including pelvic inflammatory disease, infertility, ectopic pregnancy,
neonatal infections, and increased risk HIV-1 acquisition. The high STI incidence in AGYW, which is on the rise,
emphasizes the need for effective screening strategies to reduce rates of STIs and their associated impact on
sexual and reproductive health outcomes. Among women who are at risk for HIV-1 and interested in initiating
PrEP, point-of-care diagnostic STI testing and expedited partner therapy (EPT) are two strategies that could
have a substantial impact on STI incidence. Few studies have evaluated the feasibility and acceptability of EPT
in low and middle-income countries and, to date, no studies have assessed the implementation of point-of-care
STI testing and EPT in the context of PrEP scale-up. This proposal builds on nearly a decade of collaborative
HIV/STI prevention research to conduct a prospective cohort study of AGYW eligible for PrEP in South Africa in
which we will assess the acceptability of point-of-care STI testing plus EPT and its impact on the incidence of
common curable STIs over 12 months of follow-up (Aims 1 and 2). We will undertake qualitative interviews with
participants and their male partners to identify facilitators and barriers to EPT uptake (Aim 2) and conduct a
comparative cost analysis to estimate the cost per person tested using point-of-care STI testing with and without
EPT incremental to the cost of standard of care (Aim 3). Findings from the proposed research will provide
essential knowledge for national policy makers to advance approaches to STI screening and treatment that will
lead to reductions in STIs and improvements in AGYW sexual reproductive health. The data generated from this
proposal are essential to inform efforts to reduce the burden of STIs and HIV-1 in women achieve the 2030
Sustainable Development Goals, which includes substantial reductions in HIV and STIs in key at-risk populations.
项目总结
南非的少女和年轻妇女(AGYW)是全球艾滋病毒-1发病率最高的国家之一
并且是口服暴露前预防(PrEP)以防止艾滋病毒-1感染的关键目标人群。此外,
寻求PrEP的AGYW经常经历可治愈的性传播感染(STI)的高比率。当前
南非PrEP指南建议对性传播感染进行综合征治疗,这意味着只有女性报告
症状将得到治疗。众所周知,综合症的管理尤其成问题。
对于女性来说,因为绝大多数可治愈的性传播感染是没有症状的。持续的、未经治疗的感染可能会导致
严重的生殖健康后果,包括盆腔炎、不孕、宫外孕、
新生儿感染和艾滋病毒-1感染风险增加。AGYW的高STI发病率呈上升趋势,
强调需要采取有效的筛查战略,以降低性传播感染的发病率及其对
性健康和生殖健康结果。在有HIV-1感染风险并有兴趣开始
PREP、看护点诊断性传播感染检测和快速伙伴治疗(EPT)是两种可能的策略
对性传播感染的发病率有重大影响。很少有研究评估EPT的可行性和可接受性
在低收入和中等收入国家,到目前为止,还没有研究评估护理点的实施情况
在PrEP扩大的背景下进行STI测试和EPT。这项提议建立在近十年的合作基础上
艾滋病毒/性传播感染预防研究将于#年在南非对有资格接受PrEP的AGYW进行前瞻性队列研究
我们将评估护理点性传播感染检测加EPT的可接受性及其对发病率的影响
常见的可治愈的性传播感染超过12个月的随访(目标1和2)。我们将对以下人员进行定性采访
参与者及其男性伙伴,以确定促进者和EPT摄取的障碍(目标2)并进行
比较成本分析以估算使用和不使用护理点性传播感染检测的人均成本
EPT增加了护理标准的费用(目标3)。拟议研究的结果将提供
国家政策制定者的基本知识,以推进性传播感染筛查和治疗的方法,
导致性传播感染的减少和青年性生殖健康的改善。由此产生的数据
提案对于为实现2030年妇女减少性传播感染和艾滋病毒-1负担的努力提供信息至关重要
可持续发展目标,其中包括大幅减少关键高危人群中的艾滋病毒和性传播感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer Ellen Balkus其他文献
Jennifer Ellen Balkus的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer Ellen Balkus', 18)}}的其他基金
Integrating expedited partner STI therapy during PrEP delivery for young women
在年轻女性的 PrEP 分娩过程中整合快速伴侣性传播感染治疗
- 批准号:
10466894 - 财政年份:2020
- 资助金额:
$ 60.92万 - 项目类别:
Integrating expedited partner STI therapy during PrEP delivery for young women
在年轻女性的 PrEP 分娩过程中整合快速伴侣性传播感染治疗
- 批准号:
10268256 - 财政年份:2020
- 资助金额:
$ 60.92万 - 项目类别:
Impact of the vaginal microbiome on Chlamydia trachomatis acquisition
阴道微生物组对沙眼衣原体感染的影响
- 批准号:
10082425 - 财政年份:2019
- 资助金额:
$ 60.92万 - 项目类别:
Impact of the vaginal microbiome on Chlamydia trachomatis acquisition
阴道微生物组对沙眼衣原体感染的影响
- 批准号:
10328242 - 财政年份:2019
- 资助金额:
$ 60.92万 - 项目类别:
Development and Validation of an HIV Risk Assessment Tool for African Women
为非洲妇女开发和验证艾滋病毒风险评估工具
- 批准号:
8984923 - 财政年份:2014
- 资助金额:
$ 60.92万 - 项目类别:
相似海外基金
Investigating whether chlamydia trachomatis can increase the infectivity of HPV during genital tract infections
研究沙眼衣原体是否可以增加生殖道感染期间 HPV 的传染性
- 批准号:
10648156 - 财政年份:2023
- 资助金额:
$ 60.92万 - 项目类别:
Development of a multivalent rVSV vaccine against different Chlamydia trachomatis urogenital infections
针对不同沙眼衣原体泌尿生殖道感染的多价 rVSV 疫苗的开发
- 批准号:
488750 - 财政年份:2023
- 资助金额:
$ 60.92万 - 项目类别:
Operating Grants
Identifying Chlamydia trachomatis factors that mediate PD-L1 upregulation
鉴定介导 PD-L1 上调的沙眼衣原体因子
- 批准号:
10724569 - 财政年份:2023
- 资助金额:
$ 60.92万 - 项目类别:
The influence of rectal Chlamydia trachomatis infections on immunity and incident urogenital infections in women without an indication forrectal screening
直肠沙眼衣原体感染对无直肠筛查指征的女性免疫和泌尿生殖感染事件的影响
- 批准号:
10703789 - 财政年份:2023
- 资助金额:
$ 60.92万 - 项目类别:
The role of Chlamydia trachomatis specific HLA-E restricted CD8 T cell responses in clearance of infection
沙眼衣原体特异性 HLA-E 限制性 CD8 T 细胞反应在感染清除中的作用
- 批准号:
10646837 - 财政年份:2023
- 资助金额:
$ 60.92万 - 项目类别:
Understanding how motors drive the pathogenesis in host cells infected with Chlamydia trachomatis.
了解马达如何驱动感染沙眼衣原体的宿主细胞的发病机制。
- 批准号:
491115 - 财政年份:2023
- 资助金额:
$ 60.92万 - 项目类别:
Fellowship Programs
CRISPR interference of essential stage-specific gene function in Chlamydia trachomatis
CRISPR 干扰沙眼衣原体必需阶段特异性基因功能
- 批准号:
10644789 - 财政年份:2023
- 资助金额:
$ 60.92万 - 项目类别:
Cervicovaginal microbiome, mucosal immunity, and pathogen factors that contribute to spontaneous clearance of Chlamydia trachomatis
宫颈阴道微生物群、粘膜免疫和有助于沙眼衣原体自发清除的病原体因素
- 批准号:
10463072 - 财政年份:2022
- 资助金额:
$ 60.92万 - 项目类别:
iSampleSmart!, an innovative, App-facilitated self-sampling screen and treat strategy for common bacterial STIs (Chlamydia trachomatis and Neisseria gonorrhoeae) for Canadian key populations
iSampleSmart!,一种创新的、应用程序辅助的自我采样筛查和治疗策略,适用于加拿大重点人群的常见细菌性传播感染(沙眼衣原体和淋病奈瑟菌)
- 批准号:
472740 - 财政年份:2022
- 资助金额:
$ 60.92万 - 项目类别:
Operating Grants
Dissecting the role of the Inclusion membrane protein IncE, a master multi-tasking scaffolding protein, in the pathogenesis of Chlamydia trachomatis infections
剖析包涵膜蛋白 IncE(一种主要的多任务支架蛋白)在沙眼衣原体感染发病机制中的作用
- 批准号:
10453533 - 财政年份:2022
- 资助金额:
$ 60.92万 - 项目类别: